Denali Therapeutics Inc. Profile Avatar - Palmy Investing

Denali Therapeutics Inc.

Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151…
Biotechnology
US, South San Francisco [HQ]
US Spending For DNLI Over Time · Important Awards

Government Awards Analysis

Obligations Over-Time

Awards
Obligations

Denali Therapeutics Inc. has no obligation with a government/award agency.

Latest Obligations

Contracts
$
IDVs
$
Direct Payments
$
Grants
$
Loans
$
Other Payments
$
vs.
Contracts
$
IDVs
$
Direct Payments
$
Grants
$
Loans
$
Other Payments
$
YoY Trends
  • No trends presentable, due to the lack of government contracts at all.

Spending By Type

Awards
Obligations
Contracts IDV Contracts Grants Loans Direct Other

Denali Therapeutics Inc. can't present spending by time.

Contract Analysis Updated: Recently

There are no contract award details available for Denali Therapeutics Inc.